success
infect
replic
persist
host
virus
evolv
numer
strategi
take
control
multipl
cellular
process
includ
target
transmembran
tm
signal
transduct
mediat
immun
receptor
despit
tremend
advanc
recent
year
exact
molecular
mechan
underli
critic
point
viral
pathogenesi
remain
unknown
opinion
base
novel
model
immun
signal
signal
chain
homooligomer
school
model
suggest
specif
mechan
use
differ
virus
human
immunodefici
viru
hiv
cytomegaloviru
cmv
sever
acut
respiratori
syndrom
coronaviru
sarscov
herpesviru
saimiri
hv
human
herpesviru
etc
modul
host
immun
respons
mediat
member
famili
multichain
immun
recognit
receptor
mirr
also
demonstr
school
model
togeth
lesson
learn
viral
pathogenesi
use
practic
ration
drug
design
develop
new
therapi
immun
disord
mirr
recognit
domain
signal
sequenc
contain
immunoreceptor
tyrosinebas
activ
motif
itam
locat
separ
subunit
bound
togeth
noncoval
tm
interact
figur
base
novel
biophys
phenomenon
homointeract
intrins
disord
protein
school
model
mirr
signal
uncov
molecular
mechan
cluster
extracellular
recognit
domain
lead
receptor
trigger
model
suggest
mirr
engag
lead
receptor
oligomer
coupl
multistep
structur
reorgan
driven
homooligomer
signal
subunit
figur
importantli
model
base
specif
proteinprotein
interactionsbiochem
process
influenc
control
provid
promis
drug
design
approach
within
model
specif
blockad
disrupt
tm
interact
caus
physic
function
disconnect
mirr
subunit
figur
antigen
stimul
predissoci
receptor
lead
reorient
cluster
recognit
signal
subunit
result
signal
oligom
form
itam
tyr
residu
becom
phosphoryl
signal
cascad
initi
figur
contrast
predissoci
prevent
format
signal
oligom
signal
subunit
cluster
specif
antibodi
trigger
cell
activ
illustr
predict
molecularli
explain
school
model
manipul
mirr
signal
perform
numer
unrel
virus
throughout
life
cycl
context
abil
virus
develop
centuri
evolut
modul
cell
receptor
tcr
signal
play
crucial
role
viral
pathogenesi
lymphotrop
virus
viru
may
inhibit
tcr
signal
disarm
receptor
success
enter
cell
similar
strategi
use
viru
persist
cell
reactiv
produc
infecti
particl
virus
modul
tcr
signal
use
inhibit
cell
respons
infect
cell
structur
tcr
member
mirr
famili
b
antigenbind
subunit
bound
electrostat
tm
interact
three
signal
homoand
heterodim
ff
figur
suggest
school
model
interact
promis
therapeut
target
also
repres
import
point
viral
attack
tm
peptid
capabl
inhibit
tcrmediat
cell
activ
first
report
vast
major
find
report
tcr
core
peptid
cp
synthet
peptid
correspond
sequenc
tcra
tm
domain
tmd
known
interact
tmd
f
interestingli
cell
activ
via
antibodi
affect
peptid
tabl
shown
tcr
cp
might
proper
treatment
human
cellmedi
dermatos
substitut
corticosteroid
howev
despit
extens
studi
mode
action
clinic
relev
peptid
explain
school
model
first
introduc
recent
inhibit
cell
activ
report
fusion
peptid
fp
found
n
terminu
hiv
envelop
glycoprotein
data
first
demonstr
fp
function
fuse
virion
host
cell
membran
also
immunomodulatori
activ
peptid
inhibit
antigenbut
cell
activ
vitro
immunosuppress
activ
mice
tabl
similar
tcr
cp
hiv
fp
suggest
treatment
cellmedi
patholog
howev
mode
action
peptid
remain
unexplain
school
model
first
appli
area
consid
similar
fp
cp
pattern
immunomodulatori
activ
tabl
two
electroposit
residu
primari
sequenc
school
model
reason
suggest
similar
mode
action
peptid
figur
briefli
cp
fp
compet
tcra
bind
ff
result
function
disconnect
subunit
figur
prevent
format
f
signal
oligom
thu
inhibit
cell
activ
upon
stimul
antigen
antibodi
figur
therebi
suggest
molecular
explan
use
antibodi
hiv
therapi
augment
immun
activ
interestingli
school
mechan
one
consist
experiment
data
immunomodulatori
action
hiv
fp
tcr
cp
report
far
charg
distribut
pattern
fusion
protein
region
surprisingli
conserv
mani
unrel
virus
show
similar
tcr
cp
hiv
fp
figur
thu
highli
probabl
protein
would
also
target
tcr
tm
interact
use
school
mechan
exploratori
sequenc
investig
fp
sarscov
lassa
viru
lasv
lymphocyt
choriomening
viru
lcmv
mopeia
viru
mopv
tacarib
viru
tacv
reveal
close
similar
posit
electroposit
residu
figur
intriguingli
analysi
unrel
virus
yield
similar
correl
primari
structur
function
earlier
studi
report
inhibitori
effect
lymphocyt
prolifer
peptid
synthet
peptid
sequenc
correspond
highli
conserv
region
tm
protein
human
anim
retrovirus
includ
tm
protein
human
lymphotrop
viru
type
interestingli
peptid
correspond
region
hiv
tm
protein
homolog
highli
conserv
immunosuppress
sequenc
contain
within
tm
protein
anim
human
retrovirus
respect
also
report
inhibit
lymphoprolifer
shown
simplifi
axial
view
prevent
format
signal
oligom
upon
antigen
antibodi
stimul
thu
inhibit
antigenmedi
tcr
trigger
cell
activ
primari
sequenc
analysi
proven
predict
immunomodulatori
sequenc
viral
fusion
protein
region
domain
show
similar
charg
distribut
pattern
two
essenti
posit
charg
residu
shown
blue
space
apart
three
four
seven
eight
amino
acid
e
suggest
similar
mechan
use
divers
virus
pathogenesi
modul
host
immun
respons
note
although
threedimension
structur
analyz
sequenc
within
cell
membran
known
might
assum
sequenc
may
adopt
helic
conform
upon
membran
bind
thu
helic
wheel
project
use
illustr
purpos
suggest
mode
action
depend
particular
secondari
structur
sequenc
recent
filovir
peptid
correspond
acid
domain
filovir
glycoprotein
resembl
immunosuppress
motif
retrovir
envelop
protein
demonstr
inhibit
tcrmediat
cell
activ
peptid
strike
similar
observ
charg
distribut
pattern
posit
essenti
posit
charg
residu
almost
ident
hiv
fp
figur
suggest
similar
mode
action
clearli
demonstr
differ
virus
adopt
similar
mechan
specif
target
tcr
disrupt
receptor
architectur
suppress
immun
system
importantli
virtu
acquir
insight
conserv
structur
motif
expand
predict
hypothes
conclus
deriv
answer
question
whether
share
tcrtarget
strategi
repres
conserv
function
converg
tactic
diverg
virus
gener
school
model
suggest
tm
interact
mirr
also
repres
point
viral
attack
report
recognit
human
cmv
tegument
protein
natur
killer
nk
cellactiv
receptor
lead
nk
cell
activ
instead
result
gener
inhibit
mediat
dissoci
complex
loss
abil
cell
kill
virusinfect
cell
within
context
school
model
may
target
tm
interact
f
lead
function
disconnect
f
manner
similar
action
tcr
cp
hiv
fp
figur
tm
interact
target
outsid
also
insid
cell
recent
shown
protein
downregul
tcr
surfac
express
cell
resist
activ
antigenpres
cell
control
lymphocyt
activ
often
accompani
herpesviru
reactiv
viru
might
prevent
reactiv
persist
latent
state
less
prone
immun
recognit
context
serv
maintain
equilibrium
viru
host
keep
titer
low
enough
caus
massiv
immun
activ
tcr
downregul
activ
also
report
highli
conserv
membraneproxim
sequenc
tyrosin
kinaseinteract
protein
tip
hv
notabl
primari
sequenc
hiv
fp
exhibit
similar
pattern
two
arg
residu
space
apart
eight
amino
acid
figur
posit
essenti
electroposit
residu
remark
conserv
hv
tip
relev
domain
twoinon
tio
protein
herpesviru
atel
hva
figur
thu
school
mechan
similar
appli
tcr
cp
hiv
fp
figur
use
virus
arsen
immun
evas
tactic
importantli
predict
viral
agent
prevent
antigenbut
antibodyspecif
cell
activ
figur
inde
antibodi
activ
cell
result
larg
increas
viral
replic
interestingli
increas
viral
replic
induc
activ
hivinfect
cell
current
use
purg
latent
reservoir
vivo
thu
suggest
potenti
gener
school
mechanismbas
antivir
approach
sever
import
lesson
learn
molecular
mechan
viral
pathogenesi
first
use
modern
methodolog
possibl
design
produc
tm
agent
abl
modul
immun
respons
specif
effect
virus
second
predict
tcr
cp
mani
differ
immunomodulatori
viral
sequenc
affect
similar
tcrtm
interact
suggest
gener
principl
design
tm
peptid
might
readili
use
stage
third
antibodi
mirr
signal
subunit
use
modul
affect
immun
cell
respons
viral
infect
fourth
consid
select
abil
function
disconnect
particular
tcr
signal
subunit
use
relev
peptid
power
tool
dissect
fine
mechan
viral
pathogenesi
final
two
unrel
virus
hiv
human
cmv
use
similar
mode
action
modul
host
immun
respons
mediat
two
function
differ
mirr
tcr
thu
suggest
similar
gener
mechan
use
viral
possibl
nonvir
pathogen
conclus
rather
target
virusspecif
protein
process
would
advantag
transfer
therapeut
strategi
target
redund
process
found
among
number
virus
addit
demonstr
similar
function
natur
hiv
fp
synthet
deriv
clinic
relev
tcr
cp
viral
immun
evas
strategi
transfer
therapeut
strategi
requir
similar
function
virus
repres
year
evolut
effici
optim
come
along
therefor
viral
function
studi
foreign
process
effici
strategi
use
attempt
immun
evas
immunomodul
